He noted adjusted EBIT margin expansion to 18.7%, up 260 basis points year-over-year. Adjusted EPS for the quarter was $1.45, reflecting 23% growth. Saccaro highlighted productivity improvements ...

while Adjusted EPS increased 12% versus Q4 last year. This performance was driven by ahead of plan sales, an increase in gross margin, and better than expected progress in our supply chain ...

HealthEquity expects FY26 adjusted EPS of $3.57–$3.74, vs. the $3.71 consensus. Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street veteran who ...